SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Prenetics Q3 Revenue Rises 228%; Widens H2 EBITDA Loss Outlook

Q3 2026 revenue was $64.1 million, up approximately 228% year over year, while the period loss was $25.4 million. Prenetics expects a second-half adjusted EBITDA loss of $30–35 million, versus $8–12 million expected in August, and reaffirmed FY2026 revenue guidance of $220–230 million.

PRE

Prenetics reported Q3 2026 revenue of $64.1M, up approximately 228% year over year, and a period loss of $25.4M. It expects a second-half Adjusted EBITDA loss of $30—35M, versus $8—12M expected in August, while reaffirming FY2026 revenue guidance of $220—230M and FY2027 IM8 revenue guidance of $400…

Related stories